Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: Clinical implications

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 5, 2005, Pages 2522-2530

  Alesci, Salvatore ^a,b   Martinez, Pedro E ^a   Kelkar, Sujata ^b   Ilias, Ioannis ^b   Ronsaville, Donna S ^a   Listwak, Samuel J ^a   Ayala, Alejandro R ^b   Licinio, Julio ^c   Gold, Herman K ^d   Kling, Mitchel A ^a   Chrousos, George P ^b   Gold, Philip W ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 6;

ADULT; ALGORITHM; ARTICLE; BODY MASS; CHEMOLUMINESCENCE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENTROPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; ISCHEMIC HEART DISEASE; MAJOR DEPRESSION; MALE; MENSTRUAL CYCLE; MOOD; OSTEOPOROSIS; PLASMA; PRIORITY JOURNAL; SELF REPORT; VISUAL ANALOG SCALE;

ADULT; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; MALE; MIDDLE AGED; PAIN MEASUREMENT;

EID: 21044444562     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1667     Document Type: Article

References (55)

1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS 2003 The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095-3105
2. Gold PW, Goodwin FK, Chrousos GP 1988 Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1). N Engl J Med 319:348-353
3. Gold PW, Goodwin FK, Chrousos GP 1988 Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). N Engl J Med 319:413-420
4. Gold PW, Chrousos GP 2002 Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 7:254-275
5. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ 1998 Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 158:1422-1426
6. Ariyo AA, Haan M, Tangen CM, Rutledge JC, Cushman M, Dobs A, Furberg CD 2000 Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 102:1773-1779
7. Rudisch B, Nemeroff CB 2003 Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 54:227-240
8. Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, Gold P 1996 Bone mineral density in women with depression. N Engl J Med 335:1176-1181
9. Schweiger U, Weber B, Deuschle M, Heuser I 2000 Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-up. Am J Psychiatry 157:118-120
10. Cizza G, Ravn P, Chrousos GP, Gold PW 2001 Depression: a major, unrecognized risk factor for osteoporosis? Trends Endocrinol Metab 12:198-203
11. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP 1998 The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128:127-137
12. Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS 1993 Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133:2523-2530
13. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R 2003 Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 100:9090-9095
14. Mastorakos G, Chrousos GP, Weber JS 1993 Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77:1690-1694
15. Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP 1994 Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab 79:934-939
16. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP 1996 Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 271:E601-E605
17. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP 1997 Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 66:54-62
18. Barton BE 1997 IL-6: insights into novel biological activities. Clin Immunol Immunopathol 85:16-20
19. Nijsten MW, Hack CE, Helle M, ten Duis HJ, Klasen HJ, Aarden LA 1991 Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 109:761-767
20. Gallo O, Gori AM, Attanasio M, Martini F, Giusti B, Brunelli T, Gallina E 1995 Interleukin-6 and acute-phase proteins in head and neck cancer. Eur Arch Otorhinolaryngol 252:159-162
21. Kerr R, Stirling D, Ludlam CA 2001 Interleukin 6 and haemostasis. Br J Haematol 115:3-12
22. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V 2000 Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209-214
23. Angeli A, Dovio A, Sartori ML, Masera RG, Ceoloni B, Prolo P, Racca S, Chiappelli F 2002 Interactions between glucocorticoids and cytokines in the bone microenvironment. Ann NY Acad Sci 966:97-107
24. Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311
25. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC 1992 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891
26. Chrousos GP 2000 Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J Allergy Clin Immunol 106:S275-S291
27. Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard SR 2003 Cytokine-induced sickness behavior. Brain Behav Immun 17(Suppl 1):S112-S118
28. Ershler WB, Sun WH, Binkley N, Gravenstein S, Volk MJ, Kamoske G, Klopp RG, Roecker EB, Daynes RA, Weindruch R 1993 Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 12:225-230
29. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW 1997 Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 82:4196-4200
30. Sothern RB, Roitman-Johnson B, Kanabrocki EL, Yager JG, Roodell MM, Weatherbee JA, Young MR, Nenchausky BM, Scheving LE 1995 Circadian characteristics of circulating interleukin-6 in men. J Allergy Clin Immunol 95:1029-1035
31. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, Prolo P, Wong ML, Licinio J, Gold PW, Hermida RC, Mastorakos G, Chrousos GP 1999 Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84:2603-2607
32. Vgontzas AN, Zoumakis M, Papanicolaou DA, Bixler EO, Prolo P, Lin HM, Vela-Bueno A, Kales A, Chrousos GP 2002 Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism 51:887-892
33. Vgontzas AN, Zoumakis M, Bixler EO, Lin HM, Prolo P, Vela-Bueno A, Kales A, Chrousos GP 2003 Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab 88:2087-2095
34. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R 1995 Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34:301-309
35. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H 1997 Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9:853-858
36. Brambilla F, Maggioni M 1998 Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand 97:309-313
37. Ahearn EP 1997 The use of visual analog scales in mood disorders: a critical review. J Psychiatr Res 31:569-579
38. Wewers ME, Lowe NK 1990 A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13:227-236
39. Mojon A, Fernandez JR, Hermida RC 1992 Chronolab: an interactive software package for chronobiologic time series analysis written for the Macintosh computer. Chronobiol Int 9:403-412
40. Fernandez JR, Hermida RC 1998 Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol Int 15:191-204
41. Crofford LJ, Kalogeras KT, Mastorakos C, Magiakou MA, Wells J, Kanik KS, Gold PW, Chrousos GP, Wilder RL 1997 Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 82:1279-1283
42. Johnson ML, Straume M 1999 Innovative quantitative neuroendocrine techniques. In: Veldhuis JD, Giustina A, eds. Sex-steroid interactions with growth hormone. New York: Springer-Verlag; 318-326
43. Pincus SM 2001 Assessing serial irregularity and its implications for health. Ann NY Acad Sci 954:245-267
44. Veldhuis JD, Pincus SM, Garcia-Rudaz MC, Ropelato MG, Escobar ME, Barontini M 2001 Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome. J Clin Endocrinol Metab 86:3772-3778
45. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH 2000 Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772
46. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel MJ, Ziegler R, Pfeilschifter J 2001 Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 86:2032-2042
47. Nakchbandi IA, Mitnick MA, Lang R, Gundberg C, Kinder B, Insogna K 2002 Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 87:4946-4951
48. Moffoot AP, O'Carroll RE, Bennie J, Carroll S, Dick H, Ebmeier KP, Goodwin GM 1994 Diurnal variation of mood and neuropsychological function in major depression with melancholia. J Affect Disord 32:257-269
49. Goodwin FK, Wirz-Justice A, Wehr TA 1982 Evidence that the pathophysiology of depression and the mechanism of action of antidepressant drugs both involve alterations in circadian rhythms. Adv Biochem Psychopharmacol 32:1-11
50. Healy D 1987 Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders. Psychopharmacology (Berl) 93:271-285
51. Pincus SM, Veldhuis JD, Mulligan T, Iranmanesh A, Evans WS 1997 Effects of age on the irregularity of LH and FSH serum concentrations in women and men. Am J Physiol 273:E989-E995
52. Veldman RG, Frolich M, Pincus SM, Veldhuis JD, Roelfsema F 2001 Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia. J Clin Endocrinol Metab 86:1562-1567
53. Geiss A, Varadi E, Steinbach K, Bauer HW, Anton F 1997 Psychoneuroimmunological correlates of persisting sciatic pain in patients who underwent discectomy. Neurosci Lett 237:65-68
54. Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, Fehm HL, Born J 1998 Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 83:1573-1579
55. Pollak Y, Yirmiya R 2002 Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 5:389-399